| Perennial Income Generator Fund (Managed Fund) (EIGA) |
Financials |
$28 |
EIGA Monthly Portfolio Disclosure
|
30 Apr 2025 3:14PM |
$3.720 |
$3.820 |
risen by
2.69%
|
|
| Cannindah Resources Limited (CAE) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 3:14PM |
$0.048 |
$0.039 |
fallen by
18.75%
|
|
CAE - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drilling continued targeting extensions of the Cannindah Breccia Mineral Resource.
- 1,024m of diamond drilling completed during the period.
- High-grade gold intercepts were identified, including 1m @ 31.07 g/t Au.
- New board appointments include Mr. John Morrison and Mr. Tony Rovira.
- Exploration Manager and Technical Advisor Mr. Cameron Switzer appointed.
- Ongoing verification sampling and assessment in priority areas.
- Cash and cash equivalents at quarter end were $1,560,000.
- Company plans to conduct further exploration activities in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Black Rock Mining Limited (BKT) ORDINARY FULLY PAID |
Materials |
$34 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 3:13PM |
$0.020 |
$0.016 |
fallen by
20%
|
|
BKT - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities up to 31 March 2024.
- Mahenge Graphite Project in Tanzania remains the primary focus.
- Ongoing negotiations with Tanzanian Government on framework agreement.
- Progress in securing project financing and offtake agreements.
- Discussions with international financial institutions and export credit agencies regarding debt funding.
- Strong engagement with Tanzanian regulatory authorities.
- Details provided on cash outflows, cash position, and expenditure for the quarter.
- Commitment to advancing Mahenge project toward construction and production.
- Outlook includes continued focus on funding, regulatory approvals, and commercial activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sg Fleet Group Limited (SGF) ORDINARY FULLY PAID |
Industrials |
- |
Implementation of Scheme of Arrangement
|
30 Apr 2025 3:11PM |
$3.490 |
$3.490 |
fallen by
0%
|
|
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2025 3:06PM |
$0.001 |
$0.022 |
risen by
2,100%
|
|
RBR - Price-sensitive ASX Announcement
Full Release
Key Points
- RBR Group Limited focuses on camp supply and labor services in Mozambique's LNG projects.
- The company raised $1.3 million through a capital raising program.
- RBR is pursuing additional in-country alliances to enhance its capabilities.
- Tender submitted for a 3000 person camp for Total Energies on Afungi Peninsula.
- Binding MOU secured with Field Ready group for training and employability programs.
- LNG project activities in Northern Mozambique are accelerating despite challenges.
- The change in government leadership has renewed interest from energy majors.
- RBR's subsidiaries are actively participating in significant tenders for camp construction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,184 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2025 3:06PM |
$2.200 |
$3.180 |
risen by
44.55%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd is focused on developing next-generation radiopharmaceuticals.
- The FDA granted three Fast Track Designations for SAR-bisPSMA.
- Clarity's cash position is approximately $106 million after receiving an R&D Tax Incentive.
- The company will prioritize the development of SAR-bisPSMA for prostate cancer.
- Two theranostic trials CL04 and COMBAT have been closed to focus resources.
- The SECuRE trial has entered the Cohort Expansion Phase with promising results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Top Shelf International Holdings Ltd (TSI) ORDINARY FULLY PAID |
Consumer Staple |
- |
Adjourned AGM Further Update
|
30 Apr 2025 3:05PM |
$0.040 |
$0.040 |
fallen by
0%
|
|
| Belararox Limited (BRX) ORDINARY FULLY PAID |
Materials |
$18 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 3:00PM |
$0.083 |
$0.066 |
fallen by
20.48%
|
|
BRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling commenced at Tambo South with initial hole reaching approximately 1,000 meters.
- Visual copper mineralisation was observed with significant copper sulphides reported.
- Drilling at Malambo began on February 7, 2025, with extensive fieldwork completed.
- Cash position at the end of the quarter was A$6.8 million with zero debt.
- Ongoing exploration activities include upcoming assays and regional mapping.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vertex Minerals Limited (VTX) ORDINARY FULLY PAID |
Materials |
$52 |
Application for quotation of securities - VTX
|
30 Apr 2025 3:00PM |
$0.235 |
$0.180 |
fallen by
23.40%
|
|
| Altair Minerals Limited (ALR) ORDINARY FULLY PAID |
Materials |
$179 |
ALR March 2025 Quarterly Activities Report & Appendix 5B
|
30 Apr 2025 2:59PM |
$0.002 |
$0.030 |
risen by
1,400%
|
|
ALR - Price-sensitive ASX Announcement
Full Release
Key Points
- Altair Minerals Limited (ALR) released its March 2025 Quarterly Activities Report and Appendix 5B.
- The company focused on advancing the Kipawa Rare Earth Project in Quebec, Canada, with ongoing strategic and technical initiatives.
- Drilling programs and metallurgical test work at Kipawa progressed as planned, with results underpinning the project’s feasibility studies.
- ALR continued engagement with First Nations groups and local stakeholders to support project development and permitting.
- The company maintained a strong financial position, with adequate cash reserves to fund planned exploration and development activities.
- Expenditure during the quarter was primarily allocated to exploration, project advancement, and corporate administration costs.
- No significant changes occurred in the company’s tenement holdings or capital structure during the reporting period.
- ALR remains committed to growing its portfolio of critical minerals projects and delivering value to shareholders.
- The Appendix 5B cash flow report detailed the inflows and outflows for the quarter, confirming prudent financial management.
- Future activities will focus on progressing Kipawa towards development readiness and evaluating further project opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eInvest Better Future (Managed Fund) (IMPQ) |
Financials |
$33 |
IMPQ Monthly Portfolio Disclosure
|
30 Apr 2025 2:59PM |
$4.760 |
$4.260 |
fallen by
10.50%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
Appendix 4C and Quarterly Activities Report - March 2025
|
30 Apr 2025 2:58PM |
$0.100 |
$0.067 |
fallen by
33%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued development and advancement of Photosoft technology for cancer therapy.
- Ongoing research and development activities with preparations for clinical trials.
- Business development and engagement with potential partners.
- Operating expenditure primarily focused on R&D and company operations.
- Minimal cash receipts as Invion does not yet generate significant revenue.
- Engagement with regulatory authorities to support future clinical trials.
- Maintained adequate cash reserves for operational needs.
- No related party payments other than standard director fees.
- Emphasis on strategic progress and prudent cash management to facilitate future commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$159 |
Quarterly Report - January to March 2025
|
30 Apr 2025 2:55PM |
$0.061 |
$0.087 |
risen by
42.62%
|
|
TER - Price-sensitive ASX Announcement
Full Release
Key Points
- TerraCom Limited reported coal production and sales volumes for its key sites during January-March 2025.
- Financial results include revenue, EBITDA, operational costs, and cash flow details.
- Market conditions, including global coal price movements and demand trends, are discussed.
- Operational updates cover safety performance, project developments, and site-specific highlights.
- The report addresses cost control measures and productivity initiatives.
- Management commentary provides strategic outlook and forward guidance.
- Community and stakeholder engagement activities are summarized.
- The company faced both operational challenges and achievements during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RocketDNA Ltd (RKT) ORDINARY FULLY PAID |
Information Technology |
$26 |
Investor Webinar on Tuesday 6 May, 11am AEST
|
30 Apr 2025 2:55PM |
$0.010 |
$0.022 |
risen by
120%
|
|
| DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$9 |
Quarterly Activities Report and Appendix 4C
|
30 Apr 2025 2:55PM |
$0.007 |
$0.010 |
risen by
42.86%
|
|
DTI - Price-sensitive ASX Announcement
Full Release
Key Points
- DTI Group Limited released its Quarterly Activities Report and Appendix 4C for the quarter ended 31 March 2023.
- The company reported cash receipts from customers of $2.8 million for the quarter.
- Operating cash outflows were $2.3 million, with a net operating cash inflow of $0.44 million.
- There were no receipts from government grants or tax incentives during the quarter.
- The company did not enter or terminate any loan facilities, nor did it spend any cash on acquisitions or disposals.
- Cash at the end of the quarter was $2.8 million.
- DTI continued to deliver on new and existing contracts and highlighted progress on several key customer projects.
- The company remains focused on cost control and cash management.
- Payments to related parties and associates totaled $0.08 million, primarily for directors’ fees.
- The quarterly report included the standard Appendix 4C disclosure as required for ASX-listed entities.
- No dividends were paid during the period.
- DTI’s outlook emphasizes ongoing contract execution and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$123 |
Quarterly Cashflow Report
|
30 Apr 2025 2:54PM |
$0.460 |
$0.560 |
risen by
21.74%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cash receipts totaled $25.8 million.
- Net cash outflow from operating activities was $2.1 million.
- Ending cash balance was $20.2 million.
- Cash outflows aligned with business plans and expectations.
- SomnoMed is sufficiently funded for anticipated activities.
- No need to raise further capital in the next two quarters.
- Payments to directors and related parties were made for fees and consulting.
- Compliance statements and confirmations of funding adequacy are included.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stonehorse Energy Limited (SHE) ORDINARY FULLY PAID |
Energy |
$8 |
Quarterly Activity and Cashflow Report
|
30 Apr 2025 2:54PM |
$0.006 |
$0.011 |
risen by
83.33%
|
|
SHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Stonehorse Energy Limited (SHE) provided a quarterly update covering activities and cashflows for the period ending 30 June 2023.
- The company’s main focus was on production from its portfolio of non-operated oil and gas assets primarily located in Oklahoma, USA.
- No new drilling or investment activities were initiated during the quarter.
- Production and revenue details were provided, demonstrating steady performance from existing operations.
- The company reported its cash position and noted net cash outflows in the quarter, mainly related to operational and administrative costs.
- SHE continues to review and assess potential growth opportunities in the oil and gas sector.
- The board remains committed to disciplined financial management and optimizing shareholder value.
- No payments were made to related parties other than standard director fees during the reporting period.
- The report confirms that the company is in a sound financial position and will maintain its investment strategy with caution.
- Future outlook includes ongoing evaluation of the company’s asset portfolio and pursuit of value-accretive opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$123 |
Quarterly Activities Report
|
30 Apr 2025 2:53PM |
$0.460 |
$0.560 |
risen by
21.74%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly revenue growth supported by strong sales of sleep apnea oral appliances.
- Positive market response and broader adoption of SomnoDent® Avant™.
- Ongoing clinical studies and regulatory engagement to reinforce clinical evidence and expand indications.
- Expansion of commercial activities and distribution channels, especially in the US and European markets.
- Maintained a strong cash position with disciplined cost controls.
- Continued investment in digital transformation and operational efficiencies.
- Board and management confident in executing strategic growth initiatives.
- Reaffirmation of commitment to shareholder value and long-term business sustainability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Group 6 Metals Limited (G6M) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2025 2:53PM |
$0.025 |
$0.025 |
fallen by
0%
|
|
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$70 |
Application for quotation of securities - JLL
|
30 Apr 2025 2:52PM |
$0.600 |
$0.685 |
risen by
14.17%
|
|
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$17 |
Notice of Annual General Meeting/Proxy Form
|
30 Apr 2025 2:52PM |
$0.004 |
$0.010 |
risen by
150%
|
|
| Lunnon Metals Limited (LM8) ORDINARY FULLY PAID |
Materials |
$76 |
Investor Presentation - Shaw and Partners Gold Conference
|
30 Apr 2025 2:51PM |
$0.223 |
$0.340 |
risen by
52.81%
|
|
LM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Lunnon Metals Limited is focused on the Kambalda Nickel Project in Western Australia.
- The company has achieved multiple nickel discoveries and resource upgrades since listing in 2021.
- Significant exploration success has been realized at Baker, Foster, Jan, and Northern Flats prospects.
- The total Mineral Resource Estimate (MRE) at KNP has materially increased, with additional upside potential.
- Lunnon aims to advance feasibility studies and prepare for potential mining approvals and development.
- The company leverages established infrastructure, including concentrators and haulage routes in the region.
- Kambalda is a historic, high-grade nickel camp with a proven production track record.
- Nickel market fundamentals are driven by growing demand in the electric vehicle and battery sectors.
- Lunnon maintains a strong balance sheet to support ongoing exploration and development activities.
- Strategic partnerships and experienced management underpin the company’s growth plans.
- Exploration is ongoing to test new targets and expand known resources.
- The company provides a leveraged exposure to nickel with a focus on sustainable value creation for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mindax Limited (MDX) ORDINARY FULLY PAID |
Materials |
$71 |
Quarterly Activities Report
|
30 Apr 2025 2:50PM |
$0.077 |
$0.030 |
fallen by
61.04%
|
|
MDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Mindax Limited continues development of the Mt Forrest Iron Project, focusing on feasibility studies and infrastructure assessment.
- Engagement with stakeholders, government authorities, and potential funding and offtake partners remains ongoing.
- Exploration activities continue alongside the progression of project approvals and strategic partnerships.
- The company provides a summary of its financial position, including cash balances and details on cash outflows for the quarter.
- Corporate updates include board structure and a strategy centered on advancing core projects.
- Mindax is committed to enhancing shareholder value through project advancement and diligent corporate management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mindax Limited (MDX) ORDINARY FULLY PAID |
Materials |
$71 |
Quarterly Cashflow Report Appendix 5B
|
30 Apr 2025 2:50PM |
$0.077 |
$0.030 |
fallen by
61.04%
|
|
MDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly cashflow report covers the period ending 31 March 2023.
- Detailed breakdown of cash inflows and outflows from operating, investing, and financing activities.
- Active exploration and evaluation at the Mt Forrest Project.
- Administrative and corporate costs are tracked and disclosed.
- Mindax focuses on prudent cash management and maintaining adequate funding.
- Financing activities contributed to cash inflows during the quarter.
- Report includes statements on compliance with ASX Listing Rules and corporate regulations.
- Directors have made required certifications regarding the report's accuracy and completeness.
- The company provides commentary on its financial health and strategic priorities going forward.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$226 |
Notification of cessation of securities - PCX
|
30 Apr 2025 2:49PM |
$1.995 |
$1.985 |
fallen by
0.50%
|
|
Call 1300 880 160
Start a chat
Schedule a call
